What are the major opportunities in the HIV Drugs market? What are the strategies for the HIV Drugs market?

For detailed insights on the major opportunities and strategies in the HIV Drugs market, Read More

How does the HIV Drugs market relate to the overall economy and other similar markets?

For detailed insights on HIV Drugs's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the HIV Drugs industry?

For detailed insights on the mergers and acquisitions in the HIV Drugs industry, Read More

What are the key dynamics influencing the HIV Drugs market growth? SWOT analysis of the HIV Drugs market.

For detailed insights on the key dynamics influencing the HIV Drugs market growth and SWOT analysis of the HIV Drugs industry, Read More

HIV Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

HIV Drugs Market Report 2026

Name: HIV Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Other Types ), By Administration (Oral, Parenteral), By Application (Hospital Pharmacies, Retail Pharmacies, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

HIV Drugs Market Overview

• HIV Drugs market size has reached to $36.55 billion in 2025

• Expected to grow to $43.08 billion in 2030 at a compound annual growth rate (CAGR) of 3.4%

• Growth Driver: Elevated Awareness Initiatives Driving HIV Drug Market Growth

• Market Trend: Strategic Partnerships in the HIV Drugs Market to Manufacture Lenacapavir

• North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under HIV Drugs Market?

HIV drug refers to an antiretroviral drug that is frequently used to treat HIV. HIV medications prevent the spread of the human immunodeficiency virus (HIV) or other retroviruses in the body. HIV can cause AIDS if it is not treated (acquired immunodeficiency syndrome). Currently, there is no cure that works well.

The main types of HIV drugs are nucleoside reverse transcriptase inhibitors (NRTs), non-nucleoside reverse transcriptase inhibitors (NNRT’s), protease inhibitors, integrate inhibitors, fusion inhibitors, chemokine receptor inhibitors, and others. Nucleoside reverse transcriptase inhibitors (NRTIs) are structural nucleoside analogs of DNA nucleotides that inhibit HIV-1 RT and viral replication by preventing reverse transcription of the HIV genome. The drugs are administered through oral and parenteral methods that are used by hospital pharmacies, retail pharmacies, online pharmacies, and others.

HIV Drugs Market Global Report 2026 Market Report bar graph

What Is The HIV Drugs Market Size and Share 2026?

The hiv drugs market size has grown steadily in recent years. It will grow from $36.55 billion in 2025 to $37.69 billion in 2026 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to approval of first antiretroviral drugs, widespread awareness campaigns, expansion of hiv testing programs, growth of global healthcare infrastructure, initial government funding for hiv research.

What Is The HIV Drugs Market Growth Forecast?

The hiv drugs market size is expected to see steady growth in the next few years. It will grow to $43.08 billion in 2030 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to emergence of long-acting therapies, advancement in precision medicine, integration of ai in drug discovery, expansion of healthcare access in emerging markets, development of combination antiretroviral therapies. Major trends in the forecast period include personalized antiretroviral therapy, long-acting injectable hiv drugs, hiv drug resistance monitoring, combination therapy development, access programs in emerging markets.

Book your 30 minutes free consultation with our research experts

Global HIV Drugs Market Segmentation

1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Other Types

2) By Administration: Oral, Parenteral

3) By Application: Hospital Pharmacies, Retail Pharmacies, Other Applications

Subsegments:

1) By Nucleoside Reverse Transcriptase Inhibitors (NRTIs): Zidovudine (AZT), Lamivudine (3TC), Abacavir (ABC), Tenofovir disoproxil fumarate (TDF)

2) By Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Efavirenz (EFV), Nevirapine (NVP), Etravirine (ETR), Rilpivirine (RPV)

3) By Protease Inhibitors (PIs): Ritonavir (RTV), Lopinavir (LPV), Darunavir (DRV), Atazanavir (ATV)

4) By Integrase Strand Transfer Inhibitors (INSTIs): Raltegravir (RAL), Dolutegravir (DTG), Bictegravir (BIC)

5) By Other Types: Entry Inhibitors, Fusion Inhibitors, Combination Therapies

What Are The Drivers Of The HIV Drugs Market?

Increasing awareness among people regarding the diagnosis and treatment of HIV disease acts as an important driver for the growth of the HIV drug market. Awareness of HIV refers to people’s knowledge of its diagnosis, treatment, and prevention to enable timely detection and management. Increasing awareness of HIV promotes early testing and treatment, improving health outcomes and reducing transmission. HIV drugs help raise awareness by highlighting the importance of treatment and encouraging people to get tested and seek care, reinforcing public understanding of HIV management and prevention. For instance, in July 2024, according to the United Nations International Children's Emergency Fund (UNICEF), a US-based humanitarian aid organization, an estimated 40.0 million people were living with HIV worldwide in 2023. Therefore, increasing awareness among people regarding the diagnosis and treatment of HIV disease acts as an important driver for the growth of the HIV drug industry.

The increased government spending is expected to boost the growth of the HIV drugs market going forward. Government spending, also known as public spending or government expenditure, refers to the total amount of funds that a government allocates and disburses to finance its various functions, programs, and services. Increased government funding supports various aspects of the HIV drug market, from research and development to improving access, and awareness, and reducing the societal and economic burden of the disease. These investments have a positive impact on the market's growth and overall effectiveness in addressing the HIV or AIDS pandemic. For instance, in March 2023, according to the Budget of the U.S. Government report, published by the US government, in Joe Biden's Fiscal Year (FY) 2024 budget proposal, around $850 million was allocated in funding for the CDC, HRSA, IHS, and NIH to sustain and expand the implementation of the Ending the HIV epidemic in the U.S. initiative. This marks a substantial increase of $277 million (48%) compared to the funding level enacted in FY23. Therefore, the increased government spending is driving the growth of the HIV drug industry.

Key Players In The Global HIV Drugs Market

Major companies operating in the hiv drugs market are Gilead Sciences Inc., Johnson & Johnson, Merck & Co. Inc., Boehringer Ingelheim International GmbH, Cipla, Aurobindo Pharma, AbbVie, Emcure Pharmaceuticals, Micro Labs Limited, Northeast Pharmaceutical Group Co. Ltd, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd, Strides Arcolab Limited, Hetero Labs Limited, Shanghai Desano Bio-pharmaceutical Co., Anhui Biochem Biopharmaceutical Co. Ltd., Shanghai Xinxing Medicine Co. Ltd., China Meheco Xinxing Pharma Co. Ltd., CytoDyn Inc., Janssen Pharmaceutical, Roche Laboratories, Mylan N.V., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Teva Canada, ViiV Healthcare Canada, GSK, Abbott Laboratories, Aspen Pharmacare Limited, Pharmacare Ltd.

Global HIV Drugs Market Trends and Insights

Major companies in the HIV drugs market are forming strategic partnerships to manufacture Lenacapavir to accelerate drug development, expand access to treatments, and enhance their global market presence. Lenacapavir is a first-in-class HIV-1 capsid inhibitor that works effectively in combination with other antiretrovirals and targets multiple stages of the HIV lifecycle, making it a promising option for patients with limited treatment alternatives. For instance, in August 2023, Dr. Reddy's Laboratories, an India-based pharmaceutical company, and Hetero, an India-based pharmaceutical company partnered with Gilead Sciences Inc. With this partnership, Dr. Reddy's Laboratories and Hetero aims to manufacture and distribute the HIV drug lenacapavir in 120 primarily low- and lower-middle-income countries (LMICs). This initiative aims to broaden access to this innovative treatment, which is particularly beneficial for heavily treatment-experienced patients with multi-drug-resistant HIV. Gilead Sciences Inc. is a US-based biopharmaceutical company.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the HIV drugs market share in 2025. Middle East is expected to be the largest growing region in the global HIV drug market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the HIV Drugs Market?

The HIV drug market consists of sales of Tivicay, Triumeq, Truvada, and Vemlidy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the HIV Drugs Market Report 2026?

The hiv drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hiv drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

HIV Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$37.69 billion
Revenue Forecast In 2035	$43.08 billion
Growth Rate	CAGR of 3.1% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Administration, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Gilead Sciences Inc., Johnson & Johnson, Merck & Co. Inc., Boehringer Ingelheim International GmbH, Cipla, Aurobindo Pharma, AbbVie, Emcure Pharmaceuticals, Micro Labs Limited, Northeast Pharmaceutical Group Co. Ltd, Dr. Reddy's Laboratories Ltd., Sun Ph
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. HIV Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global HIV Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. HIV Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global HIV Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Personalized Antiretroviral Therapy

4.2.2 Long-Acting Injectable Hiv Drugs

4.2.3 Hiv Drug Resistance Monitoring

4.2.4 Combination Therapy Development

4.2.5 Access Programs In Emerging Markets

5. HIV Drugs Market Analysis Of End Use Industries

5.1 Hospital Pharmacies

5.2 Retail Pharmacies

5.3 Specialty Clinics

5.4 Government Health Programs

5.5 Ngos & Community Health Organizations

6. HIV Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global HIV Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global HIV Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global HIV Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global HIV Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global HIV Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global HIV Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. HIV Drugs Market Segmentation

9.1. Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nucleoside Reverse Transcriptase Inhibitors (NRT’s), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s), Protease Inhibitors, Integrase strand transfer inhibitors (INSTIs), Other Types

9.2. Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral

9.3. Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Other Applications

9.4. Global HIV Drugs Market, Sub-Segmentation Of Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Zidovudine (AZT), Lamivudine (3TC), Abacavir (ABC), Tenofovir disoproxil fumarate (TDF)

9.5. Global HIV Drugs Market, Sub-Segmentation Of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Efavirenz (EFV), Nevirapine (NVP), Etravirine (ETR), Rilpivirine (RPV)

9.6. Global HIV Drugs Market, Sub-Segmentation Of Protease Inhibitors (PIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ritonavir (RTV), Lopinavir (LPV), Darunavir (DRV), Atazanavir (ATV)

9.7. Global HIV Drugs Market, Sub-Segmentation Of Integrase Strand Transfer Inhibitors (INSTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Raltegravir (RAL), Dolutegravir (DTG), Bictegravir (BIC)

9.8. Global HIV Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Entry Inhibitors, Fusion Inhibitors, Combination Therapies

10. HIV Drugs Market Regional And Country Analysis

10.1. Global HIV Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global HIV Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific HIV Drugs Market

11.1. Asia-Pacific HIV Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China HIV Drugs Market

12.1. China HIV Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India HIV Drugs Market

13.1. India HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan HIV Drugs Market

14.1. Japan HIV Drugs Market Overview

14.2. Japan HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia HIV Drugs Market

15.1. Australia HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia HIV Drugs Market

16.1. Indonesia HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea HIV Drugs Market

17.1. South Korea HIV Drugs Market Overview

17.2. South Korea HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan HIV Drugs Market

18.1. Taiwan HIV Drugs Market Overview

18.2. Taiwan HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia HIV Drugs Market

19.1. South East Asia HIV Drugs Market Overview

19.2. South East Asia HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe HIV Drugs Market

20.1. Western Europe HIV Drugs Market Overview

20.2. Western Europe HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK HIV Drugs Market

21.1. UK HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany HIV Drugs Market

22.1. Germany HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France HIV Drugs Market

23.1. France HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy HIV Drugs Market

24.1. Italy HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain HIV Drugs Market

25.1. Spain HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe HIV Drugs Market

26.1. Eastern Europe HIV Drugs Market Overview

26.2. Eastern Europe HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia HIV Drugs Market

27.1. Russia HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America HIV Drugs Market

28.1. North America HIV Drugs Market Overview

28.2. North America HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA HIV Drugs Market

29.1. USA HIV Drugs Market Overview

29.2. USA HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada HIV Drugs Market

30.1. Canada HIV Drugs Market Overview

30.2. Canada HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America HIV Drugs Market

31.1. South America HIV Drugs Market Overview

31.2. South America HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil HIV Drugs Market

32.1. Brazil HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East HIV Drugs Market

33.1. Middle East HIV Drugs Market Overview

33.2. Middle East HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa HIV Drugs Market

34.1. Africa HIV Drugs Market Overview

34.2. Africa HIV Drugs Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. HIV Drugs Market Regulatory and Investment Landscape

36. HIV Drugs Market Competitive Landscape And Company Profiles

36.1. HIV Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. HIV Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. HIV Drugs Market Company Profiles

36.3.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Cipla Overview, Products and Services, Strategy and Financial Analysis

37. HIV Drugs Market Other Major And Innovative Companies

Aurobindo Pharma, AbbVie, Emcure Pharmaceuticals, Micro Labs Limited, Northeast Pharmaceutical Group Co. Ltd, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd, Strides Arcolab Limited, Hetero Labs Limited, Shanghai Desano Bio-pharmaceutical Co., Anhui Biochem Biopharmaceutical Co. Ltd., Shanghai Xinxing Medicine Co. Ltd., China Meheco Xinxing Pharma Co. Ltd., CytoDyn Inc., Janssen Pharmaceutical

38. Global HIV Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The HIV Drugs Market

40. HIV Drugs Market High Potential Countries, Segments and Strategies

40.1 HIV Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 HIV Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 HIV Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global HIV Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global HIV Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global HIV Drugs Market, Supply Chain Analysis

Table 4: Global HIV Drugs Market, Major Raw Material Providers

Table 5: Global HIV Drugs Market, Major Resource Providers

Table 6: Global HIV Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global HIV Drugs Market, Major Distributors And Channel Partners

Table 8: Global HIV Drugs Market, Key Technologies & Future Trends

Table 9: Global HIV Drugs Market, Major Trends

Table 10: Global HIV Drugs Market, Major End Users

Table 11: Global HIV Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global HIV Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global HIV Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global HIV Drugs Market - TAM, US$ Billion, 2025

Table 15: Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global HIV Drugs Market, Sub-Segmentation Of Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global HIV Drugs Market, Sub-Segmentation Of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global HIV Drugs Market, Sub-Segmentation Of Protease Inhibitors (PIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global HIV Drugs Market, Sub-Segmentation Of Integrase Strand Transfer Inhibitors (INSTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global HIV Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global HIV Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global HIV Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global HIV Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global HIV Drugs Market - Company Scoring Matrix

Table 99: Gilead Sciences Inc. Financial Performance

Table 100: Johnson & Johnson Financial Performance

Table 101: Merck & Co. Inc. Financial Performance

Table 102: Boehringer Ingelheim International GmbH Financial Performance

Table 103: Cipla Financial Performance

Table 104: Global HIV Drugs Market, Competitive Benchmarking (In USD Billions)

Table 105: Global HIV Drugs Market, Competitive Dashboard

Table 106: Global HIV Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, HIV Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 108: Global, HIV Drugs Market Size Gain ($ Billion), Segmentation By Administration, 2025 – 2030

Table 109: Global, HIV Drugs Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global HIV Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global HIV Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global HIV Drugs Market, Supply Chain Analysis

Figure 4: Global HIV Drugs Market, Major Raw Material Providers

Figure 5: Global HIV Drugs Market, Major Resource Providers

Figure 6: Global HIV Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global HIV Drugs Market, Major Distributors And Channel Partners

Figure 8: Global HIV Drugs Market, Key Technologies & Future Trends

Figure 9: Global HIV Drugs Market, Major Trends

Figure 10: Global HIV Drugs Market, Major End Users

Figure 11: Global HIV Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global HIV Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global HIV Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global HIV Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global HIV Drugs Market, Sub-Segmentation Of Nucleoside Reverse Transcriptase Inhibitors (NRTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global HIV Drugs Market, Sub-Segmentation Of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global HIV Drugs Market, Sub-Segmentation Of Protease Inhibitors (PIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global HIV Drugs Market, Sub-Segmentation Of Integrase Strand Transfer Inhibitors (INSTIs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global HIV Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global HIV Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global HIV Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global HIV Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global HIV Drugs Market - Company Scoring Matrix

Figure 99: Gilead Sciences Inc. Financial Performance

Figure 100: Johnson & Johnson Financial Performance

Figure 101: Merck & Co. Inc. Financial Performance

Figure 102: Boehringer Ingelheim International GmbH Financial Performance

Figure 103: Cipla Financial Performance

Figure 104: Global HIV Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global HIV Drugs Market, Competitive Dashboard

Figure 106: Global HIV Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, HIV Drugs Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 108: Global, HIV Drugs Market Size Gain ($ Billion), Segmentation By Administration, 2025 – 2030

Figure 109: Global, HIV Drugs Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Industry Forecast: Plasma Fractionation Market to Generate $50.54 Billion Revenue by 2029

CAGR of 11.4% Projected for Protein Purification and Isolation Market From 2025 to 2029

Emerging Trends and Growth Drivers in the Pulmonary Arterial Hypertension Market Through 2029

Latest Market Developments in Specialty Generics Industry: Forecast 2025–2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Cytotoxic Drugs Market Report 2026 - Global Outlook – By Drug Type (Alkylating Agents, Antitumor Antibiotics, Antimetabolites, Plant Alkaloids, Other Drug Types), By Application (Oncology, Rheumatoid Arthritis, Multiple ...

Antiviral Combination Therapy Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase ...

Acne Drugs Market Report 2026 - Global Outlook – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Aci, Benzoyl Peroxide, Other Therapeutics), By End ...

Antivirals Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes )...

Hepatitis Drugs Market Report 2026 - Global Outlook – By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase Or NS5A Inhibitor Combinations, Hepatitis C Protease Or NS5A Inhibitor Combinations, NS5A Inhibitor...

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

Anti-Infective Drugs Market - By Type (Antibiotics, Antivirals, Antifungals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classifi...

Frequently Asked Questions

How big is the HIV Drugs Market?

The HIV Drugs market was valued at $36.55 billion in 2025, increased to $37.69 billion in 2026, and is projected to reach $43.08 billion by 2030.

What is the HIV Drugs market growth?

The global HIV Drugs market is expected to grow at a CAGR of 3.4% from 2026 to 2035 to reach $43.08 billion by 2035.

Who are the key players in HIV Drugs market?

Some Key Players in the HIV Drugs market Include, Gilead Sciences Inc., Johnson & Johnson, Merck & Co. Inc., Boehringer Ingelheim International GmbH, Cipla, Aurobindo Pharma, AbbVie, Emcure Pharmaceuticals, Micro Labs Limited, Northeast Pharmaceutical Group Co. Ltd, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd, Strides Arcolab Limited, Hetero Labs Limited, Shanghai Desano Bio-pharmaceutical Co., Anhui Biochem Biopharmaceutical Co. Ltd., Shanghai Xinxing Medicine Co. Ltd., China Meheco Xinxing Pharma Co. Ltd., CytoDyn Inc., Janssen Pharmaceutical, Roche Laboratories, Mylan N.V., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Teva Canada, ViiV Healthcare Canada, GSK, Abbott Laboratories, Aspen Pharmacare Limited, Pharmacare Ltd. .

What is the anticipated growth trend for the HIV Drugs market?

Major trend in this market includes: Strategic Partnerships in the HIV Drugs Market to Manufacture Lenacapavir. For further insights on this market. request a sample here

Which region has the most growth potential in the HIV Drugs market?

North America was the largest region in the HIV drugs market share in 2025. Middle East is expected to be the largest growing region in the global HIV drug market during the forecast period. The regions covered in the hiv drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.